Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
October 23, 2026
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.